The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR mutation type and efficacy of afatinib in patients who previously treated with EGFR-TKI.
 
Kawashima Yosuke
No Relationships to Disclose
 
Satoru Kitazono
No Relationships to Disclose
 
Natsuki Takano
No Relationships to Disclose
 
Tomoyo Oguri
No Relationships to Disclose
 
Yuichi Tambo
Honoraria - Boehringer Ingelheim
 
Noriko Yanagitani
No Relationships to Disclose
 
Atsushi Horiike
Honoraria - Chugai Pharma; Lilly Japan
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); MSD Oncology (Inst); Quintiles (Inst)
 
Fumiyoshi Ohyanagi
Honoraria - Chugai Pharma
Speakers' Bureau - Boehringer Ingelheim
 
Takeshi Horai
No Relationships to Disclose
 
Makoto Nishio
No Relationships to Disclose